Nav: Home

One's internal clock could be targeted to prevent or slow the progression of breast cancer

February 13, 2020

DUARTE, Calif. -- City of Hope scientists have identified an unlikely way to potentially prevent or slow the progression of aggressive breast cancer: target one's internal clock.

Often taken for granted, the circadian rhythm is gaining traction as a potential catalyst or brake for the onset of disease. For example, studies have shown that women who take frequent night shifts have disrupted internal clocks and increased risk of developing breast cancer. Now, City of Hope's David K. Ann, Ph.D., and his colleagues think they may have found a new role for the "clock gene": It is linked to triple-negative breast cancer, an aggressive form of the disease that often results in a poorer prognosis.

"We are the first to highlight the circadian protein BMAL1 as a tumor suppressor that interacts with the metabolism of prediabetic, obese people," said Ann, senior author of a new study and the Morgan & Helen Chu Dean's Chair of the Irell and Manella Graduate School of Biological Sciences at City of Hope. "Loss of BMAL1 in a prediabetic or obese environment gives breast cancer progression the competitive edge. This finding brings us one small step closer to the ability to provide more personalized breast cancer care based on an individual's genetics and lifestyle choices."

The retrospective study, to be published in the Feb. 21 issue of Cell Press' iScience, is a proof-of-concept investigation based on City of Hope's initial bioinformatics observations. Subsequent laboratory work used cell and mouse models to test the new hypothesis, which resulted in City of Hope scientists establishing a link among circadian rhythm, cell metabolism, breast cancer progression and nutritional health. Because obesity is a risk factor in many cancers, the City of Hope researchers next will look into how the clock gene may affect prediabetic, obese people with other major cancer types.

"The growing number of public databases in cancer genomics has afforded us the opportunity to generate hypotheses and validate discoveries for translational research," said Ching Ouyang, Ph.D., assistant research professor in the Center for Informatics and the Department of Computational and Quantitative Medicine at City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. "City of Hope is a unique comprehensive cancer center that fosters collaboration. Physicians, researchers and data scientists find trends in clinical and laboratory data and work together to develop novel therapies."

In this study, the researchers found that obese, prediabetic mice without the BMAL1 protein derived from their clock gene experienced accelerated breast tumor growth compared to their lean animal model peers. Additionally, breast tumors spread to the lungs more quickly in obese mice, suggesting that BMAL1 is a novel target that can suppress tumor progression or metastasis in a prediabetic, obese environment.

Though more research is needed, Ann said that in the distant future, a doctor could determine an individual's BMAL1 levels, especially in tumors, as well as order blood work to understand the person's nutritional health. If BMAL1 levels are low and the individual is prediabetic or clinically obese, perhaps a not-yet-developed drug could be prescribed to increase BMAL1 levels. Additionally, the physician could advise the patient to reconsider her dietary habits.

"Although additional research is needed, something people can consider doing now is to eat smaller meals at more frequent intervals, decrease sugar intake, avoid high-fat foods and exercise more," Ann said.
-end-
Cassandra A. Ramos, Ph.D., is the first author of the study and a doctoral graduate of City of Hope's Irell & Manella Graduate School of Biological Sciences. She is now employed at the Center for Science in the Public Interest, a nonprofit that focuses on nutrition and food safety. Other key co-authors include City of Hope's Mark LaBarge, Ph.D., professor in the Department of Population Sciences, and Victoria L. Seewaldt, M.D., the Ruth Ziegler Chair in Population Sciences.

This research was supported by the National Institutes of Health's National Cancer Institute (R01CA220693), U.S. Department of Defense (BC141351) and a City of Hope Center for Cancer and Aging predoctoral fellowship (P30CA033572).

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope's translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is the highest ranked cancer hospital in the West, according to U.S. News & World Report's Best Hospitals: Specialty Ranking. Its main campus is located near Los Angeles, with additional locations throughout Southern California. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

City of Hope

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at Radiolab.org/donate.